PRESSURE BIOSCIENCES INCPBIO

Market cap

$2.6M

P/E ratio

	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Products, services, other	1	2	1	2	2	2	2	2	1	2	2
Cost of products and services	-	-	-	609,054	834,012	1	1	1	582,854	942,383	2
Research and development	965,623	1	952,555	1	1	988,597	1	1	1	1	969,532
Selling and marketing	714,635	752,288	721,229	745,574	872,365	1	1	680,629	649,783	324,728	401,444
General and administrative	3	2	2	3	3	3	3	5	3	4	3
Total operating costs	-	-	-	-	-	-	-	-	6	6	7
Operating loss	-3,463,642	-3,327,192	-3,338,350	-3,565,182	-3,735,653	-4,647,048	-4,477,083	-5,805,534	-4,585,787	-4,185,147	-4,898,289
Interest expense, net	-	-	-	4	5	6	4	5	8	14	10
Unrealized (loss) gain on investment in equity securities	-	-	-	-	-	-	-	-	500,358	-457,025	3,662
Gain (loss) on extinguishment of liabilities	-	-	-	-	-	-	-	-	-	-1,061,073	-751,335
Other income (expense)	-	-	-	-	-	-	-	-	-	-	7,849
Total other expense	11,423	-757,235	-1,274,190	-3,850,116	1	-6,068,513	-5,222,235	-6,072,551	-11,419,756	-15,968,339	-11,178,389
Net loss	-3,450,205	-4,084,427	-4,612,540	-7,415,298	-2,706,984	-10,715,561	-9,699,318	-11,660,917	-16,005,543	-20,153,486	-16,076,678
Deemed dividends on beneficial conversion feature	-	-	-	-	-	-	-	-	-	873,798	-
Preferred stock dividends	950,010	1	2	23,194	-	-	-	-	2	2	2
Net loss attributable to common shareholders	-4,400,215	-5,247,449	-6,251,726	-7,438,492	-2,706,984	-	-23,473,150	-15,868,083	-17,584,710	-22,685,459	-17,803,953
Basic and diluted net loss per share attributable to common shareholders	-	-	-	-	-	-	-	-	-	-	-1.61